BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25122204)

  • 1. Population-based incidence and prevalence of facioscapulohumeral dystrophy.
    Deenen JC; Arnts H; van der Maarel SM; Padberg GW; Verschuuren JJ; Bakker E; Weinreich SS; Verbeek AL; van Engelen BG
    Neurology; 2014 Sep; 83(12):1056-9. PubMed ID: 25122204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of functional impairment in Facioscapulohumeral muscular dystrophy.
    Statland JM; Tawil R
    Muscle Nerve; 2014 Apr; 49(4):520-7. PubMed ID: 23873337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The French National Registry of patients with Facioscapulohumeral muscular dystrophy.
    Guien C; Blandin G; Lahaut P; Sanson B; Nehal K; Rabarimeriarijaona S; Bernard R; Lévy N; Sacconi S; Béroud C
    Orphanet J Rare Dis; 2018 Dec; 13(1):218. PubMed ID: 30514324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living with facioscapulohumeral muscular dystrophy during the first two COVID-19 outbreaks: a repeated patient survey in the Netherlands.
    Deenen JCW; Kools J; Greco A; Thewissen R; van de Put W; Lanser A; Joosten LAB; Verbeek ALM; van Engelen BGM; Voermans NC
    Acta Neurol Belg; 2024 Apr; 124(2):559-566. PubMed ID: 38218752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry.
    Evangelista T; Wood L; Fernandez-Torron R; Williams M; Smith D; Lunt P; Hudson J; Norwood F; Orrell R; Willis T; Hilton-Jones D; Rafferty K; Guglieri M; Lochmüller H
    J Neurol; 2016 Jul; 263(7):1401-8. PubMed ID: 27159994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventilatory support in facioscapulohumeral muscular dystrophy.
    Wohlgemuth M; van der Kooi EL; van Kesteren RG; van der Maarel SM; Padberg GW
    Neurology; 2004 Jul; 63(1):176-8. PubMed ID: 15249635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
    Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
    BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facioscapulohumeral Dystrophy in Childhood: A Nationwide Natural History Study.
    Goselink RJM; Schreuder THA; van Alfen N; de Groot IJM; Jansen M; Lemmers RJLF; van der Vliet PJ; van der Stoep N; Theelen T; Voermans NC; van der Maarel SM; van Engelen BGM; Erasmus CE
    Ann Neurol; 2018 Nov; 84(5):627-637. PubMed ID: 30179273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).
    Hilbert JE; Kissel JT; Luebbe EA; Martens WB; McDermott MP; Sanders DB; Tawil R; Thornton CA; Moxley RT;
    Contemp Clin Trials; 2012 Mar; 33(2):302-11. PubMed ID: 22155025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the influence of smoking and alcohol consumption on clinical severity in patients with facioscapulohumeral muscular dystrophy.
    Vincenten SCC; Mul K; Schreuder THA; Voermans NC; Horlings CGC; van Engelen BGM
    Neuromuscul Disord; 2021 Sep; 31(9):824-828. PubMed ID: 34407911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample.
    Mostacciuolo ML; Pastorello E; Vazza G; Miorin M; Angelini C; Tomelleri G; Galluzzi G; Trevisan CP
    Clin Genet; 2009 Jun; 75(6):550-5. PubMed ID: 19320656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).
    Hamel J; Johnson N; Tawil R; Martens WB; Dilek N; McDermott MP; Heatwole C
    Neurology; 2019 Sep; 93(12):e1180-e1192. PubMed ID: 31409737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy.
    Ruggiero L; Mele F; Manganelli F; Bruzzese D; Ricci G; Vercelli L; Govi M; Vallarola A; Tripodi S; Villa L; Di Muzio A; Scarlato M; Bucci E; Antonini G; Maggi L; Rodolico C; Tomelleri G; Filosto M; Previtali S; Angelini C; Berardinelli A; Pegoraro E; Moggio M; Mongini T; Siciliano G; Santoro L; Tupler R
    JAMA Netw Open; 2020 May; 3(5):e204040. PubMed ID: 32356886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal and genitourinary symptoms in facioscapulohumeral muscular dystrophy: Prevalence and impact.
    Cole MR; Cooper CS; Hanna EM; Zimmerman MB; Kinoshita J; Mathews KD
    Muscle Nerve; 2024 Mar; 69(3):325-333. PubMed ID: 38158588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms.
    Banerji CRS; Cammish P; Evangelista T; Zammit PS; Straub V; Marini-Bettolo C
    Neuromuscul Disord; 2020 Apr; 30(4):315-328. PubMed ID: 32327287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of functional outcomes in patients with facioscapulohumeral muscular dystrophy.
    Katz NK; Hogan J; Delbango R; Cernik C; Tawil R; Statland JM
    Brain; 2021 Dec; 144(11):3451-3460. PubMed ID: 34542603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. It's not just physical: a qualitative study regarding the illness experiences of people with facioscapulohumeral muscular dystrophy.
    Bakker M; Schipper K; Geurts AC; Abma TA
    Disabil Rehabil; 2017 May; 39(10):978-986. PubMed ID: 27211201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-identified disease burden in facioscapulohumeral muscular dystrophy.
    Johnson NE; Quinn C; Eastwood E; Tawil R; Heatwole CR
    Muscle Nerve; 2012 Dec; 46(6):951-3. PubMed ID: 23225386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported reduced sleep quality and excessive daytime sleepiness in facioscapulohumeral muscular dystrophy.
    Hoffmann HM; Malo-Juvera V; Statland JM
    Muscle Nerve; 2022 Oct; 66(4):487-494. PubMed ID: 35893768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.